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OBSERVATIONS
Glycemic Response
to Ingested
Dreamﬁelds Pasta
Compared With
Traditional Pasta
O
ur research group has developed
diets we refer to as Low Biologically
Available Glucose (LoBAG) diets.
These diets, in short-term studies (5–10
weeks), result in a decrease in glycated
hemoglobin that is similar to or greater
than that typically obtained with oral
medications in patients with type 2 dia-
betes (1–3). The diet is lower in carbohy-
drates (CHOs) and higher in protein and
fat than that recommended by the Amer-
ican Heart Association (4) and the U.S.
Department of Agriculture (5). It is not
ketogenic and does not require weight
loss. The diets are designated by the
CHO content, which is given as a sub-
script; for example, if the CHO content
is 30% of food energy, the diet would be
termed as a LoBAG30 diet.
In the diets we have designed, pasta
and other cereal grain products are lim-
ited. That is, we de-emphasize starch-
containing foods. This is because starch is
composed entirely of glucose, and the
glucose generally is readily available after
digestion. Thus, we were particularly
interested in the commercially available
Deamﬁelds pasta. In its advertisements,
Dreamﬁelds states that the product has a
“taste like traditional pasta, but contains
twice the ﬁber, only 5 grams of digestible
carbohydrate per serving and has a 65%
lower glycemic index (GI 13 vs. 38)”
(Dreamﬁelds informational material,
http://www.dreamﬁeldsfoods.com).
Therefore, from our perspective, it could
be a useful addition to our LoBAG diet
menus.
After numerous attempts to obtain the
data upon which the company based the
observation of a dramatically lower glyce-
mic index than that observed with tradi-
tional pasta was based, we decided to
conductourownsimple,singlemealstudy.
In this study, we have compared the
glucose response over 3 h after ingestion
of a 50-g CHO portion of the Dreamﬁelds
product with the same dry weight CHO
of a traditional commercially available
pasta. A crossover design was used. Two
groups of ﬁve subjects each, i.e., 10 sub-
jects total without known diabetes, were
recruited for the study. They were not
aware of which pasta product was being
served. Regarding taste as well as mouth
feel, our results conﬁrmed the Dreamﬁelds
company claim. All subjects agreed that
they could not detect a difference between
theDreamﬁeldsproductandthetraditional
pasta. Both were considered to be highly
acceptable. When the ﬁrst ﬁve subjects
were studied using the same cooking
methodforbothproducts,theDreamﬁelds
pastadidnotresultinasmallerglucoserise.
Tooursurprisethemeanpostmealglucose
curveswereessentiallyidentical.Therefore,
we studied ﬁve different subjects. The
result was the same; that is, the curves
were essentially identical (Fig. 1). In 10
people without diabetes, the Dreamﬁelds
pasta product we purchased did not result
in an improved glucose excursion when
compared with a commercially available
traditional pasta product as would have
been expected based upon the company’s
claim. Because we did not test several dif-
ferent batches of Dreamﬁelds pasta or
other commercially available pasta prod-
ucts for comparison, it is possible that
Figure 1—Blood glucose response following ingestion of pasta. Study #1, n 5 5( top). Study #2,
n 5 5( bottom).
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